Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2024; 15(3): 367-370
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.367
Mechanisms and potential applications of COPS6 in pan-cancer therapy
Tong Wu, Miao-Rong Ji, Lian-Xiang Luo
Tong Wu, Miao-Rong Ji, The First Clinical College, Guangdong Medical University, Zhanjiang 524023, Guangdong Province, China
Lian-Xiang Luo, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524000, Guangdong Province, China
Author contributions: Luo LX conceived and designed the editorial; Wu T and Ji MR wrote the editorial; Luo LX reviewed the paper and provided comments; All authors read and approved the final manuscript.
Conflict-of-interest statement: All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lian-Xiang Luo, PhD, Associate Professor, The Marine Biomedical Research Institute, Guangdong Medical University, No. 2 Wenming East Road, Xiashan District, Zhanjiang 524000, Guangdong Province, China. luolianxiang321@gdmu.edu.cn
Received: November 2, 2023
Peer-review started: November 2, 2023
First decision: December 31, 2023
Revised: January 11, 2024
Accepted: February 4, 2024
Article in press: February 4, 2024
Published online: March 24, 2024
Core Tip

Core Tip: COPS6 expression is often increased in malignancies, and this is associated with a poor prognosis, suggesting that it could be a potential biomarker for tumors. However, the exact role of COPS6 in different types of tumors is still unknown. This research seeks to investigate the expression of COPS6 in various tumor tissues, its prognostic value, mutations in the gene, and the correlation between expression levels and immune infiltration with different types of immune cells.